Nuzenio

Previously Treated

Previously Treated news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 20:02:00 GMT FDA Approves Jideytro for Previously Treated ROS1-Positive Lung Cancer - news.cancerconnect.comnews.cancerconnect.com · Wed, 05 Aug 2026 03:51:34 GMT Camrelizumab Plus Nab-Paclitaxel Yields Efficacy in Previously Treated Advanced Urothelial Carcinoma - OncLiveOncLive · Tue, 04 Aug 2026 15:51:00 GMT Pirtobrutinib Combo Boosts PFS in Previously Treated CLL/SLL - CancerNetworkCancerNetwork · Mon, 03 Aug 2026 14:38:54 GMT Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR NewswirePR Newswire · Mon, 03 Aug 2026 11:45:00 GMT FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance - OncodailyOncodaily · Wed, 29 Jul 2026 11:32:06 GMT Jideytro Approved for Previously Treated ROS1-Positive NSCLC - Clinical Oncology NewsClinical Oncology News · Mon, 27 Jul 2026 07:00:00 GMT Nurse adopts baby girl she previously treated in the NICU - liveaction.orgliveaction.org · Sun, 26 Jul 2026 18:00:02 GMT

Timeline

Wed, 05 Aug 2026 20:02:00 GMTRevolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewswire

Wed, 05 Aug 2026 03:51:34 GMTFDA Approves Jideytro for Previously Treated ROS1-Positive Lung Cancer - news.cancerconnect.com

Tue, 04 Aug 2026 15:51:00 GMTCamrelizumab Plus Nab-Paclitaxel Yields Efficacy in Previously Treated Advanced Urothelial Carcinoma - OncLive

Mon, 03 Aug 2026 14:38:54 GMTPirtobrutinib Combo Boosts PFS in Previously Treated CLL/SLL - CancerNetwork

Mon, 03 Aug 2026 11:45:00 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR Newswire

Wed, 29 Jul 2026 11:32:06 GMTFDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance - Oncodaily

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

FDA3 live mentions Financial Results2 live mentions Update2 live mentions FDA Approves Jideytro2 live mentions Positive Lung Cancer2 live mentions Paclitaxel Yields Efficacy2 live mentions Previously Treated Advanced2 live mentions Previously Treated CLL2 live mentions Breakthrough Therapy2 live mentions KRAS2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Previously Treated.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.